Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Pacific Biosciences Calif In (PACB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q4 | 0 | 0.00 | Sell 100.00% | 0.85 | SEC | ||
| 2018 Q3 | 12,173,094 | 0.85 | $5.41 | $65,856,000 | SEC | ||
| 2018 Q2 | 12,173,094 | 0.52 | $3.55 | $43,214,000 | SEC | ||
| 2018 Q1 | 12,173,094 | 0.34 | Add 8.46% | 0.03 | $2.05 | $24,955,000 | SEC |
| 2017 Q4 | 11,223,094 | 0.40 | Add 5.84% | 0.02 | $2.64 | $29,629,000 | SEC |
| 2017 Q3 | 10,603,944 | 0.74 | $5.25 | $55,671,000 | SEC | ||
| 2017 Q2 | 10,603,944 | 0.47 | Add 16.86% | 0.07 | $3.56 | $37,750,000 | SEC |
| 2017 Q1 | 9,073,874 | 0.60 | $5.17 | $46,912,000 | SEC | ||
| 2016 Q4 | 9,073,874 | 0.45 | Reduce 0.24% | <0.01 | $3.80 | $34,481,000 | SEC |
| 2016 Q3 | 9,095,663 | 0.97 | Add 16.30% | 0.14 | $8.96 | $81,497,000 | SEC |
| 2016 Q2 | 7,820,808 | 0.75 | Add 3.43% | 0.02 | $7.03 | $55,019,000 | SEC |
| 2016 Q1 | 7,561,268 | 1.02 | $8.50 | $64,271,000 | SEC | ||
| 2015 Q4 | 7,561,268 | 1.43 | Add 1.41% | 0.02 | $13.13 | $99,279,000 | SEC |
| 2015 Q3 | 7,456,034 | 0.49 | Add 5.59% | 0.03 | $3.66 | $27,289,000 | SEC |
| 2015 Q2 | 7,061,034 | 0.65 | $5.76 | $40,672,000 | SEC | ||
| 2015 Q1 | 7,061,034 | 0.71 | Add 9.31% | 0.06 | $5.84 | $41,236,000 | SEC |
| 2014 Q4 | 6,459,784 | 0.89 | $7.84 | $50,645,000 | SEC | ||
| 2014 Q3 | 6,459,784 | 0.53 | $4.91 | $31,718,000 | SEC | ||
| 2014 Q2 | 6,459,784 | 0.67 | $6.18 | $39,921,000 | SEC | ||
| 2014 Q1 | 6,459,784 | 0.51 | $5.35 | $34,560,000 | SEC | ||
| 2013 Q4 | 6,459,784 | 0.45 | Add 11.09% | 0.04 | $5.23 | $33,785,000 | SEC |
| 2013 Q3 | 5,814,719 | 0.45 | Add 64.63% | 0.18 | $5.52 | $32,097,000 | SEC |
| 2013 Q2 | 3,531,953 | 0.12 | $2.53 | $8,936,000 | SEC | ||
| 2013 Q1 | 3,531,953 | 0.12 | $2.49 | $8,795,000 | SEC | ||
| 2012 Q4 | 3,531,953 | 0.09 | $1.70 | $6,004,000 | SEC | ||
| 2012 Q3 | 3,531,953 | 0.09 | $1.83 | $6,463,000 | SEC | ||
| 2012 Q2 | 3,531,953 | 0.12 | Reduce 0.32% | <0.01 | $2.17 | $7,664,000 | SEC |
| 2012 Q1 | 3,543,333 | 0.19 | $3.42 | $12,118,000 | SEC | ||
| 2011 Q4 | 3,543,333 | 0.14 | $2.80 | $9,921,000 | SEC | ||
| 2011 Q3 | 3,543,333 | 0.17 | $3.21 | $11,374,000 | SEC | ||
| 2011 Q2 | 3,543,333 | 0.44 | $11.70 | $41,457,000 | SEC | ||
| 2011 Q1 | 3,543,333 | 0.54 | $13.36 | $47,330,000 | SEC | ||
| 2010 Q4 | 3,543,333 | 0.59 | Buy | 0.59 | $14.34 | $50,817,000 | SEC |